INDICATIONS: Peripheral neuropathy Chronic fatigue syndrome Diabetic neuropathy Cardiovascular support Muscle recovery and fatigue management*
This eliminates the need for BNPL entirely and protects against late fees during low-income periods
Among semaglutide users, the most commonly reported symptoms were nausea (39.4%), fatigue (16.1%), vomiting (18.0%), constipation (14.9%), and diarrhea (12.4%)
65,66 A network meta-analysis ranked SEMA 0.4 mg first in the resolution of MASH among alternative treatments [surface under the cumulative ranking (SUCRA) = 0.89], higher than liraglutide (SUCRA = 0.84) and resmetirom (SUCRA = 0.44)
Discontinue Wegovy in patients at least 2 months before a planned pregnancy Pediatric: Adverse reactions with Wegovy in pediatric patients aged 12 years with obesity were similar to those reported in adults in weight reduction trials
Phase 3: Long-Term Maintenance (Month 9+) This is the phase that stretches indefinitely